Effects of ginseng saponin on modulation of multidrug resistance

Archives of Pharmacal Research

Volumn 19, Issue 3, 1996, Pages 213-218

  Park, Jong Dae ^a   Kim, Dong Sun ^a   Kwon, Hyeok Young ^b   Son, Sang Kwon ^b   Lee, You Hui ^a   Baek, Nam In ^a   Kim, Shin Il ^a   Rhee, Dong Kwon ^b  

^a Korea Ginseng Corporation   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

20(S) ginsenoside Rg3; Ginsenosides; Multidrug resistance; Panax ginseng

Indexed keywords

EID: 0011986176     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976892     Document Type: Article

References (38)

1. Arceci, R. J., Croop, J. M., Horwitz, S. B. and Housman, D., The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc. Natl. Acad. Sci. USA, 85, 4350-4354 (1988).
2. Baek, N. I., Kim, D. S., Lee, Y. H., Park, J. D., Lee, C. B. and Kim, S. I., Cytotoxicities of ginseng saponins and their degradation products against some cancer cell lines. Arch. Pharm. Res., 18, 164-168 (1995).
3. Beck, W.T., The cell biology of multidrug resistance. Biochem. Pharmacol., 36, 2879-2887 (1987).
4. Beck, W.T., Strategies to circumvent multidrug resistance due to P-glycoprotein or to altered DNA topoisomerase II. Bull. Cancer, 77, 1131-1141 (1990).
5. Chen, H.-X., Bamberger, U., Heckel, A., Guo, X. and Cheng, Y.-C., BIBW22, a dipyridamole analog, acts as a bifunctional modulator on tumor cells by influncing both p-glycoprotein. Cancer Res., 53, 1974-1977 (1993).
6. Cole, S. P. C., The 1991 Merck Frost Award. Multidrug resistance in small cell lung cancer. Can. J. Physiol. Pharmacol., 70, 313-329 (1992).
7. Cole, S. P. and Deelay, R. G., Multidrug resistance-associated protein : sequence correction. Science (Washington D.C.), 260; 879 (1993).
8. Cole, S. P. C., Downers, H. F. and Slovak, M. L., Effect of calcium antagonists on the chemosensitivity of two drug resistant human tumor cell lines which do not overexpress P-glycoprotein. Br. J. Cancer, 59, 42-46 (1989).
9. Cole, S. P. C., Chanda, E. R., Dicke, F. P., Gerlach, J. H. and Mirski, S. E. L., Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II. Cancer Res., 51, 3345-3352 (1991).
10. Endicott, J. A. and Ling, V., The biochemistry of p-glycoprotein-mediated multidrug resistance. Ann. Rev. Biochem., 58, 137-171 (1989).
11. Fojo, A., Akiyama, S. I., Gottesman, M. M. and Pastan, I., Reduced drug accumulation in multiply drug resistant human KB carcinoma cell lines. Cancer Res., 45, 3002-3007 (1985).
12. Ford, J. M. and Hait, W. N., Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev., 42, 155-199 (1990).
13. Gaj, C. L., Anyanwutaku, I. O., Coli, S. C., Chang, Y., and Cheng, Y.C., Reversal of multidrug resistance associated protein mediated multidrug resistance in a human carcinoma cell line by the V-enanciomer of verapamil. Proceedings of the American Association for Cancer Research, 36, 346 (1995).
14. Gottesman, M. M. and Pastan, I., The multidrug transporter, a double-edged sword. J. Biol. Chem., 263, 12163-12166 (1988).
15. Gottesman, M. M. and Pastan, I., Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem., 62, 385-427 (1993).
16. Graeme, J. F., Bruce, C, B. and William, R. W., A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells. Anal. Biochem. 139, 272-277 (1984).
17. Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P. and Deeley, R. G., Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54(2), 357-366 (1994).
18. Gros, P., Ben Neriah, Y., Croop, J. M. and Housman, D. E., Isolation and expression of a complementary DNA that confers multidrug resistance. Nature, 323, 728-731 (1986).
19. Herzog, C. E., Tsokos, M., Bates, S. E. and Fojo, A.T., Increased mdr1/p-glycopro-tein expression after treatment of human colon carcinoma cells with p-glycoprotein antagonists. J. Biol. Chem. 268, 2946-2952 (1993).
20. Im, K. S., Chang, E. H. and Je, N. K., A modified alkaline hydrolysis of total ginsenosides yielding genuine agycones and prosapogenols. Arch. Pharm. Res., 18, 454-457 (1995).
21. 2 and the 20(S) epimer from protopanaxadiol saponins of Panax ginseng C. A. Meyer, Yakhak Hoeji, 35(5), 432-437 (1991a).
22. Kim, S. I., Park, J. D., Lee, Y. H., Nam, G. Y. and Baek, N. I., Preparation of 20(R)- and 20(S)-ginsenoside Rh1 from ginsenoside Re. Korean J. Ginseng Sci, 15(3), 188-191 (1991b).
23. 3, and its isomer from diol-type ginseng saponin. Yakhak Hoeji, 39(1), 85-93 (1995).
24. Kitagawa, I., Yoshikawa, M., Yoshihara, M., Hayashi, T. and Taniyama, T., Chemical studies on crude drug procession, Yakugaku Zasshi, 103, 612 (1983).
25. Kitagawa, I., Chemical studies on crude drug processing-Red and White ginseng, Taejeon, Korea, 4th Int'l. Ginseng Symp., pp. 159-168 (1984).
26. Krishinamachary, N. and Center, M. S., The MRP gene associated with a non-Pglycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res., 53, 3658-3661 (1993).
27. Lai, S-L., Goldstein, L. J., Gottesman, M. M., Pastan, I., Tsai, C-M., Johnsson, B-E., Mulshine, J. L., Ihde, D. C., Kayser, K. and Gazdar, A. F., MDR1 gene expression in lung cancer. J. Natl. Cancer Inst., 81, 1144-1150 (1989).
28. Leyland-Jones, B., Dalton, W., Fisher G. A. and Sikik, B. I.. Reversal of multidrug resistance to cancer chemotherapy. Cancer suppl., 7(11), 3484-3488 (1993).
29. Markus, R. and Werner, S., Clinical trials of agents that reverse multidrug resistance. Cancer, 72(12), 3533-3563 (1993).
30. Mirski, S. E. I., Gerlach, J. H. and Cole, S. P. C., Multidrug resistance in a human small cell lung cancer cell line selected in Adriamycin. Cancer Res., 47, 2594-2598 (1987).
31. Ozols, R. F., Molecular and clinical advances in anticancer drug resistance. Kluwer Academic Publisher, Boston (1991).
32. Pastan, I., Gottesman, M. M., Ueda, K., Lovelace, E., Rutherford, A.V. and Willingham, M. A., Retrovirus carrying an mdr1 cDNA confers multidrug resistance and polarized expression of p-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. USA., 85, 4486-4490 (1988).
33. Taylor, C. W., Dalton, W. S., Parrish, P. R., Gleason, M. C., Bellany, W. T., Thompson, F. H., Roe, D. J., and Trent, J. M. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br. J. Cancer, 63, 923-929 (1991).
34. Teeter, L.D., Drug resistance and chemotherapy: a perspective. Cancer Bulletin, 41, 14-20 (1989).
35. Tsuruo, T., Iida, H., Tsukagoshi, S. and Sakurai, Y., Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through inhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res., 41, 1967-1972 (1981).
36. Twentyman, P. R., Fox, N. E. and White, D. J. G., Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multidrug resistant human lung cancer cell line. Br. J. Cancer, 56, 55-57 (1987).
37. Ueda, K., Cardarelli, C., Gottesman, M.M. and Pastan, I., Expression of a full-length cDNA for the human mdr1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad Sci. USA., 84, 3004-3008 (1987).
38. Yang, C. P. H., DePinho, S. H., Greenberger, L. M., Arceci, R. J. and Horwitz, S. B., Progesterone interacts with P-glycoprotein in multidrug-resistant clees and the endometrium of gravid uterus. J. Biol. Chem., 265, 782-788 (1989).